CGB
Director Trades
| Date | Director | Value |
|---|
Company News
Cann Global’s clinical trials show unique cannabis strain can help slow progression of multiple sclerosis
Medical cannabis developer Cann Global (ASX: CGB) has reported successful in vitro and in vivo trials of a unique cannabis strain to slow the progression of multiple sclerosis and possibly reverse damage caused by the disease. Cann subsidiary Medical Cannabis Research Group Pty Ltd has an ongoing research funding agreement with renowned Israeli university Technion to investigate the use of cannabis […]
Cann Global to supply new hemp product range via Costco, adds sales volume in Vietnam
Hemp and medical cannabis company Cann Global (ASX: CGB) has reported an expansion in its sales and distribution activities in both Australia and overseas. Earlier today, Cann updated the market with respect to its exclusive supply deal signed with Vietnamese company EPCO Foods and its parallel supply agreement to provide its T12 product range to […]
Cann Global shoulders into ‘huge’ emerging African medicinal cannabis market
Medical cannabis company Cann Global (ASX: CGB) has shouldered into South Africa via a heads of agreement with Koegas Medicinal Herbs (Pty) Ltd to establish a joint venture medicinal cannabis production and distribution company in the region. To facilitate the joint venture, Cann will establish a local wholly-owned subsidiary Cann Global South Africa, which it […]
Cann Global secures rights to medicinal cannabis formulations used by Olivia Newton-John
Cann Global (ASX: CGB) has secured the IP rights to the medicinal cannabis formulas Olivia Newton-John has used to treat her stage four metastatic breast cancer. According to Cann, Ms Newton-John has credited the formulations known as XO 27 XP, ONJ 18 XP and ONJ XO for improving her health when used in conjunction with […]
Cann Global to lower production costs and establish a medical cannabis production operation in South East Asia
Cann Global (ASX: CGB) has decided to expand its medical cannabis business in Asia by incorporating a dedicated subsidiary that works with the APAC and Asian markets. The new company – Cann Global Asia – has been set up by the ASX-listed medical cannabis developer to focus on undertaking “legal broad-acre industrial cannabinoid (CBD) hemp […]
Company Videos
No videos found.